Drug Database
Back to search

Netherlands· NL-2a042d2d1cd3

Persantin, injectievloeistof 5 mg/ml

A dipyridamole product containing dipyridamol, registered in Netherlands by Glenwood GmbH Pharmazeutische Erzeugnisse. The same ATC class is registered in 11 of our 19 countries.

ATC B01AC07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPersantin, injectievloeistof 5 mg/mlATCB01AC07REGISTER NO.NL-2a042d2d1cd3PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dipyridamolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dipyridamole is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AC07 (dipyridamole), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search dipyridamole products by name

Dipyridamole · ATC B01AC07

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DIPYRIDAMOL
Manufacturer
Glenwood GmbH Pharmazeutische Erzeugnisse
Country
Netherlands (NL)
ATC code
B01AC07
ATC class
Dipyridamole
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    12620

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

352 interactions on record for dipyridamole.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dipyridamole against other medicinesHow interaction checks work

Dipyridamole · interactions on record

352 records

  • 47 severe
  • 93 moderate
  • 5 minor
  • 207 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dipyridamole in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dipyridamole products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Persantin
  • Bulgaria · Антистенокардин, Биокардин
  • Cyprus · Perazodin, Persantin
  • Denmark · Dipyridamol Alternova, Dipyridamol Strides
  • Spain · Persantin
  • Finland · Persantin
  • France · Persantine
  • United Kingdom (Northern Ireland) · Attia, Dipyridamole Dr. Reddy’s
  • Greece · Persantin
  • Croatia · Persantin
  • Ireland · Pyranistole
  • Iceland · Persantin
  • Italy · Corosan, Persantin
  • Malta · Perazodin
  • Norway · Aponova, Dipyridamol Glenmark
  • Portugal · Dipiridamol Labesfal, Persantin
  • Sweden · Dipyridamol Alternova, Pyranistole

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a5ab1409-b237-40e8-bdc1-1987f46afb75
GET /v1/drugs/a5ab1409-b237-40e8-bdc1-1987f46afb75?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h12620_smpc.pdf",
  "strength": null,
  "atc_label": "Dipyridamole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg12620",
  "excipients": [
    "MACROGOL",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER, GEZUIVERD",
    "WIJNSTEENZUUR, (L (+) Vorm) (E 334)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "DIPYRIDAMOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h12620.pdf",
  "authorised_at": "1988/10/25",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "12620",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about dipyridamole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console